Related Experiment Videos
[Pyoderma gangrenosum: treatment with plasma exchange (4 cases)]
A Gérard1, F Schooneman, P Voiriot
1Département de Maladies Infectieuses, CHU Brabois, Vandoeuvre.
Annales De Medecine Interne
|January 1, 1988
Summary
Plasma exchange effectively treats pyoderma gangrenosum, halting disease progression and reducing pain. This therapy offers significant benefits for patients with this rare ulcerative condition.
Area of Science:
- Dermatology
- Immunology
- Nephrology
Context:
- Pyoderma gangrenosum (PG) is a rare, ulcerative neutrophilic dermatosis.
- Associated with systemic diseases like inflammatory bowel disease.
- Limited treatment options and significant morbidity.
Purpose:
- To evaluate the efficacy of plasma exchange (PLEX) in managing pyoderma gangrenosum.
- To assess PLEX in conjunction with corticotherapy for PG treatment.
Summary:
- Four patients with PG underwent 6-12 sessions of PLEX combined with corticotherapy.
- Two patients showed very good results with interrupted progression and rapid healing.
- One patient had good results with slower pain relief, and one showed no improvement.
Impact:
- PLEX demonstrated efficacy in limiting lesion extension and reducing pain in most PG patients.
- Three out of four patients experienced no recurrences.
- PLEX is a promising therapeutic option for pyoderma gangrenosum, improving patient outcomes and quality of life.